National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Insurance Coverage: Tennessee
    Posted: 08/23/2005    Reviewed: 12/17/2008
Page Options
Print This Page
E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

Past Highlights

For more information about insurance coverage of clinical trial costs, see this feature's main page: States That Require Health Plans to Cover Patient Care Costs in Clinical Trials.


Legislation: House Bill 837

Effective: July 2005

What clinical trials are covered?

Phase I, II, III, and IV clinical trials for the treatment of cancer approved by one of the following:

  • National Institutes of Health (NIH)
  • U.S. Food and Drug Administration (FDA), in the form of an Investigational New Drug Application
  • U.S. Department of Defense
  • U.S. Department of Veterans Affairs

Who is required to pay?

  • Any health benefit plan offered by an employer; excludes individually underwritten health insurance policies.

Other key criteria:

  • The subject of the trial must evaluate a drug, medical device or service that falls within a Medicare benefit category.
  • Limits coverage to those drugs, medical devices, and services that have been approved by the FDA and that are used in the clinical managment of the patient.

Back to Top


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov